ADMA Biologics (ADMA)
Manufactures plasma-derived immune globulins for primary immune deficiency and hepatitis B exposure.
$9.56
vs last close−0.26 (−2.60%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 91.70% | 205.39M shares | |
|---|---|---|---|
| 341 holders · as of Jun 30, 2026 | |||
| Insiders | 0.85% | 1.90M shares | |
| 9 holders · as of Jul 28, 2026 | |||
| Strategic holders | 5.33% | 11.93M shares | |
| 1 holder · as of Feb 15, 2022 | |||
| Other | 2.12% | 4.76M shares | |
| remainder | |||
223.98M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
341 holders · 205.39M shares · 55 new positions · 144 increased · 149 reduced · 87 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 38.36M | 17.12% | +1.52M | Aug 7, 2026 |
| State Street Corp | 17.12M | 7.64% | +3.03M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 10.10M | 4.51% | −203.1K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 10.09M | 4.50% | +1.22M | Aug 13, 2026 |
| Rubric Capital Management LP | 9.34M | 4.17% | +7.53M | Aug 14, 2026 |
| Capital Research Global Investors | 8.76M | 3.91% | −2.43M | Aug 12, 2026 |
| First Trust Advisors LP | 7.80M | 3.48% | +7.44M | Aug 11, 2026 |
| Geode Capital Management, LLC | 6.06M | 2.71% | +235.9K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.10% | 35.91M | 13G | Apr 30, 2025 |
| State Street Corporation | 7.40% | 17.12M | 13G | Aug 7, 2026 |
| Vanguard Capital Management | 5.08% | 12.11M | 13G | Apr 29, 2026 |
| Invesco Ltd. | 5.00% | 11.79M | 13G | Feb 12, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| May 27, 2026 | Jerrold B. Grossmandirector | Purchase | 6,400 | $7.91 | 520,284 |
| May 12, 2026 | Jerrold B. Grossmandirector | Purchase | 12,500 | $8.01 | 513,884 |
| May 11, 2026 | Jerrold B. Grossmandirector | Purchase | 12,500 | $8.01 | 501,384 |
| Mar 16, 2026 | Adam S. Grossmandirector, officer: President and CEO | Sale · 2 lots | 21,000 | $15.16 | 2,112,777 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messinaofficer: COO and SVP, Compliance | Sale | 10,096 | $15.63 | 466,600 |
| Mar 5, 2026 | Steve Elmsdirector | Purchase | 7,000 | $15.67 | 2,038,730 |
| Mar 6, 2026 | Steve Elmsdirector | Purchase | 7,000 | $15.39 | 2,045,730 |
| Feb 17, 2026 | Adam S. Grossmandirector, officer: President and CEO | Sale · 2 lots | 21,000 | $16.08 | 2,284,379 |
| Dec 15, 2025 | Adam S. Grossmandirector, officer: President and CEO | Sale · 2 lots | 21,000 | $19.79 | 2,007,850 |
| Nov 19, 2025 | Adam S. Grossmandirector, officer: President and CEO | Sale · 2 lots | 21,000 | $16.00 | 2,013,850 |
House and Senate disclosures
Not reported.